Nasopharyngeal Carriage of Streptococcus pneumoniae in Children in Coastal Kenya

Am J Trop Med Hyg. 2018 Apr;98(4):1046-1050. doi: 10.4269/ajtmh.16-0813. Epub 2018 Feb 22.

Abstract

Streptococcus pneumoniae (SP) is a leading cause of child mortality globally, killing around half a million children aged 5 years and less per year. Nasopharyngeal carriage of SP is a prerequisite to disease, and the prevalence of colonization reaches 100% within the first few years of life. Serotype prevalence varies geographically, impacting the serotype coverage of pneumococcal vaccines, and serotype prevalence data are limited from large regions of the world, including sub-Saharan Africa. We enrolled 323 unvaccinated children, aged 4-7 years from coastal Kenya and obtained nasopharyngeal swab samples before and after vaccination with the 10-valent pneumococcal vaccine. Vaccination did not reduce the overall prevalence of pneumococcal carriage in our cohort, with 65 (20%) children colonized before vaccination and 63 (19.4%) colonized postvaccination. However, the prevalence of vaccine-included serotypes (vaccine strains) declined from 43% to 19% of positive swabs, whereas non-vaccine serotypes increased from 46% to 73%. This study contributes to the few data available regarding pneumococcal carriage and serotype prevalence in Kenya and is in concordance with reports of dynamic serotype replacement, driven by vaccine pressure.

MeSH terms

  • Carrier State / epidemiology
  • Child
  • Child, Preschool
  • Cohort Studies
  • Humans
  • Kenya / epidemiology
  • Nasopharynx / microbiology
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / prevention & control
  • Pneumococcal Vaccines / administration & dosage*
  • Prevalence
  • Serogroup
  • Streptococcus pneumoniae / genetics
  • Streptococcus pneumoniae / immunology*
  • Vaccination*

Substances

  • 10-valent pneumococcal vaccine
  • Pneumococcal Vaccines